Processed Foods Research Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
 

Research Project: PROCESSING AND BIOTECHNOLOGICAL IMPROVEMENT OF FOODS TO PREVENT OBESITY RELATED AND OTHER DEGENERATIVE DISEASES

Location: Processed Foods Research

Title: EXTRUSION CONDITIONS MODIFY HYPOCHOLESTEROLEMIC PROPERTIES OF WHEAT BRAN FED TO HAMSTERS

Authors

Submitted to: Cereal Chemistry
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: November 8, 2005
Publication Date: April 1, 2006
Citation: Kahlon, T.S., Berrios, J.D., Smith, G.E., Pan, J. 2006. Extrusion conditions modify hypocholesterolemic properties of wheat bran fed to hamsters. Cereal Chemistry 83(2):152-156.

Interpretive Summary: Wheat bran was extruded in a twin-screw extruder at five specific mechanical energy (SME) levels (0.120, 0.177, 0.234, 0.291 and 0.358 kWh/kg dry basis), and their cholesterol-lowering effects were compared with those of unprocessed wheat bran. Cholesterol digestibility, total liver cholesterol and total liver lipids were significantly lower with all the extruded wheat bran diets compared with the unextruded wheat bran control. Wheat bran extruded with 0.291 kWh/kg diet resulted in a 13% reduction in plasma cholesterol, a 29% reduction in low density lipoprotein cholesterol and a slight (1%) increase in high density lipoprotein cholesterol. Considering plasma, liver and fecal excretion data, wheat bran extruded at 0.291 kWh/kg appears to have the most desirable healthful potential. Data suggests that cholesterol lowering potential of wheat bran could be enhanced by optimizing the energy input used in the extrusion process.

Technical Abstract: Wheat bran was extruded in a twin-screw extruder at five specific mechanical energy (SME) levels (0.120, 0.177, 0.234, 0.291 and 0.358 kWh/kg dry basis), and their cholesterol-lowering effects were compared with those of unprocessed wheat bran when fed to four-week-old male golden Syrian hamsters (n=10 per treatment) for three weeks. Diets contained 10% total dietary fiber, 10.3% fat, 3% nitrogen and 0.4% cholesterol. Plasma total very low density lipoprotein cholesterol was significantly lower with 0.120 kWh/kg extruded wheat bran diet compared with the unextruded wheat bran control. Total triglycerides were significantly lower with 0.120 and 0.177 kWh/kg wheat bran diets compared with those fed 0.291 and 0.358 kWh/kg extruded wheat bran diets. Cholesterol digestibility, total liver cholesterol and total liver lipids were significantly lower with all the extruded wheat bran diets compared with the unextruded wheat bran control. Cholesterol digestibility for the 0.291 kWh/kg wheat bran diet was also significantly lower than all other extruded diets. Significantly more sterol were excreted with diets containing 0.291 and 0.358 kWh/kg extruded wheat bran compared with the unextruded wheat bran control. Wheat bran extruded with 0.291 kWh/kg diet resulted in a 13% reduction in plasma cholesterol, a 29% reduction in low density lipoprotein cholesterol and a slight (1%) increase in high density lipoprotein cholesterol. Considering lowest cholesterol digestibility, significantly higher sterol excretion, desirable plasma lipoprotein cholesterol profile, significantly lower liver weight, total liver lipids and liver cholesterol, wheat bran extruded at 0.291 kWh/kg appears to have the most desirable healthful potential. Data suggest that the cholesterol-lowering potential of wheat bran could be enhanced by optimizing the energy input used in the extrusion process.

   

 
Project Team
Yokoyama, Wallace - Wally
Kahlon, Talwinder
Pan, Zhongli - John
Wood, Delilah - De
McHugh, Tara
 
Publications
   Publications
 
Related National Programs
  Quality and Utilization of Agricultural Products (306)
  Human Nutrition (107)
 
Patents
  Antioxidant As An Effective Lipid Lowering Drug
 
 
Last Modified: 05/24/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House